Clinical Study Evaluating the Safety and Efficacy of IC19 CAR-T Cell Therapy for Refractory Systemic Lupus Erythematosus
Clinical trial NCT06886919 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06886919
- Sponsor
- Beijing Immunochina Medical Science & Technology Co., Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-03-31
- Primary completion
- 2025-09-30
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.